Anaerobutyricum hallii

Information

Microbe Identification

Anaerobutyricum hallii

Microbe id: PMDBM2021285
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Anaerobutyricum hallii [39488]
Taxonomy Genus: Anaerobutyricum [2569097]
Taxonomy Family: Lachnospiraceae [186803]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Anaerobutyricum hallii

Identified MGC Region
(click for details)
MGC Cluster (Most Similar) Similarity Compound metabolized by the MGC Type of MGC Reference(PubMed ID)
Unclassified gene clustern.a.Others HGD unassignedPMID: 36782070
Unclassified gene clusterGlycerol-3-POxidative glycerolPMID: 26443736
Succinate to propionate B. thetaSuccinateSuccinate to propionatePMID: 24553467
Propanediol degradation S. entericaGlycerol / ethanolaminePduPMID: 27242734 / PMID: 20234377
Pyruvate to acetate-formate E. coliPyruvatePyruvate to acetate-formatePMID: 20622067
Rnf complex C. sporogenesEnergy-capturing-relatedRnf complexPMID: 23269825
PFOR II pathway B. thetaiotaomicronAromatic amino acids / proline / glutamate / leucine / histidine / arginineOD AA metabolismPMID: 29168502 / PMID: 20937090 / PMID: 27994578 / PMID: 15654892 / PMID: 22933560 / PMID: 30183487
Acetate to butyrate C. sporogenesAcetateAcetate to butyratePMID: 17241242

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Anaerobutyricum hallii


Identified BGC Region
(click for details)
BGC Cluster (Most Similar) Similarity Compound Synthesized by the BGC Type of BGC Reference (PubMed ID)
Unclassified gene clustern.a.RanthipeptidePMID: 34019648
Unclassified gene clustern.a.NRPS,cyclic-lactone-autoinducerPMID: 34019648

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Anaerobutyricum hallii distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Anaerobutyricum hallii in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Anaerobutyricum hallii

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJEB65297🔗-3.55898922693956mNGS
Kidney Failure, Chronic PRJEB65297🔗-3.53062887117136mNGS
Hemangioma, Cavernous PRJNA629755🔗-3.48184827229393mNGS
Hemangioma, Cavernous PRJNA629755🔗-3.38706939386291mNGS
Hypertension PRJNA509999🔗-2.55024505245622mNGS
Diarrhea PRJEB14038🔗-2.38260294620432mNGS
Diarrhea PRJEB14038🔗-2.246889359211mNGS
Colorectal Neoplasms PRJNA1167935🔗-3.29397794354844mNGS
Colorectal Neoplasms PRJNA1167935🔗-3.23963552201746mNGS
Colorectal Neoplasms PRJEB53891🔗-3.09691692349646mNGS
Colorectal Neoplasms PRJNA936589🔗-3.02571446254664mNGS
Colorectal Neoplasms PRJNA1138893🔗-2.93101052233129mNGS
Colorectal Neoplasms PRJNA1138893🔗-2.80613808290887mNGS
Colorectal Neoplasms PRJNA731589🔗-2.68634251911609mNGS
Colorectal Neoplasms PRJNA731589🔗-2.61285814498863mNGS
Colorectal Neoplasms PRJNA1050885🔗4.00162680305166mNGS
Parkinson Disease PRJEB59350🔗-2.07377334041604mNGS
Colitis, Ulcerative PRJEB42155🔗-3.72116677711713mNGS
Colitis, Ulcerative PRJNA993675🔗-3.63637362046771mNGS
Colitis, Ulcerative PRJNA993675🔗-3.50240607768678mNGS
Colitis, Ulcerative PRJEB42155🔗-3.41614839791581mNGS
Campylobacter Infections PRJNA660443🔗-2.5429244096562mNGS
Campylobacter Infections PRJNA660443🔗-2.37938867896732mNGS
Carcinoma, Hepatocellular PRJNA932948🔗-3.7350268460402mNGS
Carcinoma, Hepatocellular PRJNA932948🔗-3.56340485358242mNGS
Prostatic Neoplasms PRJNA769284🔗-2.13462680416664mNGS
Leukemia, Myeloid, Acute PRJNA813705🔗-3.69049717295028mNGS
Crohn Disease PRJEB42155🔗-3.73970894460125mNGS
Crohn Disease PRJNA813736🔗-3.73028805945459mNGS
Crohn Disease PRJNA813736🔗-3.7141673779406mNGS
Crohn Disease PRJEB42155🔗-3.6376335109697mNGS
Crohn Disease PRJNA993675🔗-3.49913231123223mNGS
Crohn Disease PRJNA993675🔗-3.35951023294796mNGS
Crohn Disease PRJEB76677🔗-3.22506895187062mNGS
Crohn Disease PRJNA793776🔗-2.89140241460854mNGS
Crohn Disease PRJNA793776🔗-2.6428371775819mNGS
Crohn Disease PRJNA398089🔗2.11935663670832mNGS
Crohn Disease PRJNA398089🔗2.22457075238851mNGS
Psoriasis PRJNA938297🔗4.06617273259036mNGS
Purpura, Thrombocytopenic, Idiopathic PRJNA858062🔗-3.32028501120635mNGS
Arthritis, Rheumatoid PRJNA896336🔗3.49226761747355mNGS
Fatigue Syndrome, Chronic PRJNA751448🔗-2.88266121656553mNGS
Fatigue Syndrome, Chronic PRJNA751448🔗-2.77687821773598mNGS
Fatigue Syndrome, Chronic PRJNA379741🔗-2.65654243187729mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗-2.24232905314156mNGS
Anorexia PRJNA674716🔗-3.31289994724244mNGS
Anorexia PRJNA674716🔗-3.11712781917713mNGS
Neuroblastoma PRJEB63351🔗3.35029830924098mNGS
Neuroblastoma PRJEB63351🔗3.602472903806mNGS
Myasthenia Gravis PRJNA688881🔗-2.38588560275309mNGS
Irritable Bowel Syndrome PRJEB37924🔗3.65860724223993mNGS
Peutz-Jeghers Syndrome PRJNA905444🔗-3.40698747761962mNGS
Peutz-Jeghers Syndrome PRJNA905444🔗-3.19617604557035mNGS
Gastroesophageal Reflux PRJNA993632🔗-4.40301630681931mNGS
Gastroesophageal Reflux PRJNA993632🔗-4.32259486259675mNGS
Clostridium Infections PRJNA648321🔗-3.55902450526121mNGS
Clostridium Infections PRJNA648321🔗-3.29160094605932mNGS
Amyotrophic Lateral Sclerosis PRJEB32767🔗-3.69040356660064mNGS
Pancreatic Neoplasms PRJNA665854🔗-4.11673103902233mNGS
Cystic Fibrosis PRJNA314903🔗-3.46952386621089mNGS
Obesity PRJNA1125836🔗3.86549003923078mNGS
Obesity PRJNA1125836🔗4.0077149486708mNGS
Autism Spectrum Disorder PRJNA686821🔗-3.56814965049715mNGS
Inflammatory Bowel Diseases PRJNA511372🔗-4.47403540573462mNGS
Inflammatory Bowel Diseases PRJNA511372🔗-4.23871870326554mNGS
Inflammatory Bowel Diseases PRJNA993675🔗-3.7227397134583mNGS
Inflammatory Bowel Diseases PRJNA993675🔗-3.59930554687839mNGS
Biliary Atresia PRJNA730640🔗-2.5776365982178mNGS
Renal Insufficiency, Chronic PRJEB65297🔗-3.8178402065289mNGS
Renal Insufficiency, Chronic PRJEB65297🔗-3.69385998750995mNGS
Multiple Sclerosis PRJEB28543🔗3.75029803176144mNGS
Fibromyalgia PRJEB80379🔗-4.13211156422478mNGS
Fibromyalgia PRJEB80379🔗-4.08254794721421mNGS
COVID-19 PRJNA624223🔗-4.02118147304758mNGS
COVID-19 PRJNA624223🔗-3.44869128127198mNGS
COVID-19 PRJNA689961🔗-3.02261426834778mNGS
COVID-19 PRJDB13214🔗-2.87239047906908mNGS

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Anaerobutyricum hallii



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Anaerobutyricum hallii



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Anaerobutyricum hallii

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Anaerobutyricum hallii


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Anaerobutyricum hallii



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Anaerobutyricum hallii

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Anaerobutyricum hallii

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Anaerobutyricum hallii

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Anaerobutyricum hallii



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Anaerobutyricum hallii


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Anaerobutyricum hallii


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?